See also this year's filing and all EDGAR filings for this company.
PDF Report 0000949699_2014_Pharmacyclics_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0000949699, Pharmacyclics INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 740,801,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 25,471,000 |
| 3 | remainder_Assets | 2,479,000 |
| 4 | LiabilitiesCurrent | 87,631,000 |
| 5 | LiabilitiesNoncurrent | 1,472,000 |
| 6 | remainder_Liabilities | 52,025,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 0 |
| 9 | ResearchAndDevelopmentExpense | 85,133,000 |
| 10 | remainder_Expenses | 108,238,000 |
| 11 | remainder_Revenues | 260,510,000 |
| 12 | remainder_NetIncome | -129,000 |
| 13 | remainder_ComprehensiveNetIncome | -4,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 768,751,000 |
| 1 | Liabilities | 141,128,000 |
| 2 | Expenses | 193,371,000 |
| 3 | Revenues | 260,510,000 |
| 4 | StockholdersEquity | 627,623,000 |
| 5 | NetIncome | 67,010,000 |
| 6 | ComprehensiveNetIncome | 67,008,000 |
| 7 | BaseVar | 681,946,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.15 |
| 9 | EconomicCapitalRatio | 3.79 |
Edgar->Model Mapping
Feature Distribution
Change over Time
